Defeating COVID-19: Seroconversion Detection With ELISA

The recent and rapid spread of SARS-CoV-2 has necessitated the development of new assays that can detect the presence of the virus in patient samples or evidence of recent infection. Assays, such as the enzyme-linked immunosorbent assay (ELISA), are being developed to detect the presence of anti-SARS-CoV-2 antibodies in patient sera.

Download this article to discover an ELISA that:

• Is more sensitive than a lateral flow immunoassay
• Can reliably detect anti-spike protein antibodies in patient samples
• Reduces the likelihood of cross reactivity